Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Citius Pharmaceuticals Inc (NQ: CTXR)
1.140 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 3:50 PM EST, Jan 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) 1.110 (31)
Ask (Size) 1.200 (5)
Prev. Close 1.140
Today's Range 1.140 - 1.140
52wk Range 0.9360 - 4.600
Shares Outstanding 10,677,222
Dividend Yield N/A
Performance
YTD
+5.56%
+5.56%
1 Month
+6.54%
+6.54%
3 Month
-29.19%
-29.19%
6 Month
-55.97%
-55.97%
1 Year
-73.91%
-73.91%
Top News
More News
Citius Licenses Mino-Wrap From MD Anderson Cancer Center
- New technology designed to reduce infections after implantation of devices Read More
from PR Newswire
Citius Pharmaceuticals to Present at Biotech Showcase Investor Conference
Citius Pharmaceuticals, Inc. ("Citius") (CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that its Chief Executive Officer,... Read More
from PR Newswire
More News
Read More
Citius Pharmaceuticals Provides Updates on Mino-Lok® and CITI-002
from PR Newswire
Citius Pharmaceuticals Presentation Now Available for On-Demand Viewing
from PR Newswire
Live Investor Conference & Webinar: NYSE, NASDAQ, and OTC companies present December 6th
from PR Newswire
Citius Pharmaceuticals to Present at the 11th Annual LD Micro Main Event
from PR Newswire
Citius Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com December 6
from PR Newswire
Citius Pharmaceuticals to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
from PR Newswire
Citius Reports On Activities During Infectious Disease Week 2018
from PR Newswire
Citius Announces The Publication Of European Patent For Mino-Lok®
from PR Newswire
Citius Announces The Issuance Of The Patent On The Advanced Stability Of Mino-Lok® By USPTO
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.